SCHEMBL20055871

SCHEMBL20055871

CC1CN(c2cccc(C(=O)O)n2)C[C@@H](C)O1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.47
KDM4E B2RXH2 4/20 0.47
GAA P10253 1/20 0.47
TDP1 Q9NUW8 2/20 0.46
TSHR P16473 2/20 0.46
ALOX15 P16050 1/20 0.46
ACMSD Q8TDX5 1/20 0.46
HPGD P15428 2/20 0.45
NPSR1 Q6W5P4 1/20 0.45
KMT2A Q03164 3/20 0.43
HSD17B10 Q99714 2/20 0.43
TTR P02766 1/20 0.42
ADORA2A P29274 1/20 0.42
ADORA1 P30542 1/20 0.42
MEN1 O00255 2/20 0.42
CLK2 P49760 1/20 0.41
LRRK2 Q5S007 1/20 0.41
GNE Q9Y223 1/20 0.41
PRKDC P78527 1/20 0.41
RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16834258 1.00 ALDH1A1 (0.47) ALDH1A1KDM4EGAATDP1TSHR
SCHEMBL20055968 0.85 CRBN (0.50) ALDH1A1KDM4EGAATDP1HPGD
SCHEMBL16834789 0.85 CRBN (0.50) ALDH1A1KDM4EGAATDP1HPGD
SCHEMBL3469975 0.82 KDM4E (0.46) KDM4ETDP1TSHRALOX15ACMSD
SCHEMBL31480075 0.79 TTR (0.47) KDM4ETDP1TSHRALOX15ACMSD
SCHEMBL16834260 0.79 ALDH1A1 (0.44) ALDH1A1KDM4EGAATDP1TSHR
SCHEMBL20031456 0.78 KDM4E (0.47) KDM4ETDP1TSHRALOX15ACMSD
SCHEMBL9005458 0.77 PRKCQ (0.62) KDM4ETDP1TSHRALOX15ACMSD
SCHEMBL14818751 0.76 HTR3E (0.53) ALDH1A1KDM4EGAATDP1TSHR
SCHEMBL2909203 0.76 ALDH1A1 (0.54) ALDH1A1KDM4EGAATDP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3083586-B1 NOVEL CARBOXAMIDES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS COMPRISING THEM, AND USE THEREOF FOR PRODUCING MEDICAMENTS Bayer Pharma AG (DE) 2018-04-18 EP disclosed